Montelukast Sodium
Product Images NDC 60723-005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 60723-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

4 mg-30s Bottle Label (4mg 30s)

4 mg-30s Bottle Label (4mg 30s)
This is a description of a medication called Montelukast Sodium that comes in chewable tablet form. It is intended for pediatric patients aged 25 or younger. The tablets contain 4.2 mg of Montelukast Sodium, equivalent to 5 mg of Montelukast. It is recommended that the accompanying patient information leaflet be provided by the pharmacist. The usual dosage is not specified, but it can be found in the accompanying circular. The medication should be stored at controlled room temperature and protected from light and moisture by keeping it in the original package. It is important to keep this medication and all drugs out of reach of children. The manufacturer is Hangzhou Minsheng Binjang Pharma. Lot number and other details are not available.*
FDA Label Image

5 mg-30s Bottle Label (5mg 30s)

5 mg-30s Bottle Label (5mg 30s)
This is the description for Montelukast Sodium Chewable Tablets, used for Pediatric Patients aged 6-14 years. Each tablet contains 5.2 mg Montelukast Sodium that is equivalent to 105 mg Monteukast. The tablets come in a pack of 30 and should be stored at room temperature away from light and moisture. The usual dosage should be followed as directed by the accompanying circular. The medication contains phenylalanine, and the package should be kept out of children's reach. The manufacturer is Hangzhou Minsheng Binjang Pharma. The document was last revised in 2015, and the lot number is not available.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This appears to be a graph showing the change in height (in centimeters) over time (in weeks) for three groups: one group taking Montelukast Sodium 5 mg, another group taking Beclomethasone 336 mcg, and a third group taking a placebo. The graph suggests that there is a trend of decreasing height over time for all three groups, but the Montelukast group seems to have the smallest decrease in height.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.